Targeting bacterial 'superbugs' by innovative combination dosing strategies and new antibiotics

Project: Research

Status	Finished
Effective start/end date	1/03/15 → 28/02/19

Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis
Bulitta, J. B., Jiao, Y., Drescher, S. K., Oliver, A., Louie, A., Moya, B., Tao, X., Wittau, M., Tsuji, B. T., Zavascki, A. P., Shin, B. S., Drusano, G. L., Sörgel, F. & Landersdorfer, C. B., 6 Feb 2019, In: Clinical Pharmacokinetics. 58, 2, p. 143-156 14 p.
Research output: Contribution to journal › Article › Research › peer-review

18 Citations (Scopus)
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling
Landersdorfer, C. B., Yadav, R., Rogers, K. E., Kim, T. H., Shin, B. S., Boyce, J. D., Nation, R. L. & Bulitta, J. B., 1 Apr 2018, In: Antimicrobial Agents and Chemotherapy. 62, 4, 8 p., e02053-17.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

9 Citations (Scopus)
Characterizing the time-course of antihypertensive activity and optimal dose range of fimasartan via mechanism-based population modeling
Bulitta, J. B., Paik, S. H., Chi, Y. H., Kim, T. H., Shin, S., Landersdorfer, C. B., Jiao, Y., Yadav, R. & Shin, B. S., 30 Sept 2017, In: European Journal of Pharmaceutical Sciences. 107, p. 32-44 13 p.
Research output: Contribution to journal › Article › Research › peer-review

4 Citations (Scopus)

Project Details